Pemetrexed

Pemetrexed

SCHEMBL124673

Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1.[LiH]

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTTYMSthyA

The experimentally established mechanism targets of Pemetrexed. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GART known ✓ P22102 10/20 0.76
DHFR known ✓ P00374 6/20 0.76
TYMS known ✓ P04818 5/20 0.76
FOLR1 P15328 4/20 0.76
SLC46A1 Q96NT5 4/20 0.76
ATIC P31939 3/20 0.76
FOLR2 P14207 3/20 0.76
SLC19A1 P41440 3/20 0.76
SHMT1 P34896 2/20 0.76
FRK P42685 1/20 0.76
SHMT2 P34897 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pemetrexed SCHEMBL19411240 1.00 GART (0.76) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL19410627 0.99 GART (0.75) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL7969 0.99 GART (0.77) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL7968 0.99 GART (0.77) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL2549428 0.99 GART (0.77) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL6034765 0.99 GART (0.77) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL1934793 0.98 GART (0.76) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL124663 0.98 GART (0.76) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL126068 0.98 GART (0.76) GARTDHFRTYMSFOLR1SLC46A1
Pemetrexed SCHEMBL15648731 0.98 GART (0.76) GARTDHFRTYMSFOLR1SLC46A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213674-B1 PURIFICATION METHOD OF PEMETREXED SALTS,SODIUM SALTS AND DISODIUM SALTS CHONGQING PHARM RES INST CO (CN) 2012-03-07 EP disclosed
US-20100305319-A1 METHOD OF PURIFYING A SALT, SODIUM SALT AND DISODIUM SALT OF PEMETREXED Chongquing Pharmaceutical Research Institute Co. ltd (CN) 2010-12-02 US disclosed
EP-2213674-A1 PURIFICATION METHOD OF PEMETREXED SALTS,SODIUM SALTS AND DISODIUM SALTS Chongqing Pharmaceutical Research Institute Co., Ltd. (CN) 2010-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305319-A1 METHOD OF PURIFYING A SALT, SODIUM SALT AND DISODIUM SALT OF PEMETREXED SLC13A3, SLC34A3, SLC28A1 GART 1306/4885DHFR 117/4885TYMS 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.